Sanofi News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

15.12.23	Press Release: Availability of the Q4 2023 Memorandum for modelling purposes (EN, Sanofi-Aventis)
15.12.23	Press Release: EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa (EN, Sanofi-Aventis)
12.12.23	Sanofi Terminates Pompe Disease Drug Agreement With Maze Therapeutics Following FTC Opposition (RTTNews)
11.12.23	Press Release: Statement on FTC challenge to proposed license agreement with Maze Therapeutics (EN, Sanofi-Aventis)
11.12.23	Press Release: Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone (EN, Sanofi-Aventis)
07.12.23	Sanofi: Sarclisa Phase 3 Trial Meets Primary Endpoint Of Progression Free Survival (RTTNews)
07.12.23	Press Release: Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed multiple myeloma not eligible for transplant (EN, Sanofi-Aventis)
07.12.23	Sanofi Says Developing 12 Experimental Medicines (RTTNews)
07.12.23	Press Release: Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to Industry Leadership in Immunology (EN, Sanofi-Aventis)
01.12.23	Press Release: Sanofi’s Consumer Healthcare unit launches the Shared Care Collective, an advisory group working to advance sustainability (EN, Sanofi-Aventis)
27.11.23	Sanofi Posts Positive NOTUS Trial Result Of Dupixent In COPD (RTTNews)
02.11.23	Sanofi honors 10 advocacy organizations promoting health equity solutions in underserved U.S. communities (PR Newswire)
01.11.23	Sanofi launches "The 1 Pledge" movement to drive early screening for type 1 diabetes in the U.S. (PR Newswire)
30.10.23	MeiraGTx Says Sanofi Acquired 4 Mln Shares For $30 Mln; MeiraGTx Up In Pre-market (RTTNews)
27.10.23	Sanofi Q3 Profit Rises, Backs FY23 View, To Split Consumer Healthcare Unit; Stock Dips (RTTNews)
27.10.23	Sanofi Q3 Profit Rises; To Separate Consumer Healthcare Business (RTTNews)
23.10.23	Regeneron : Dupixent Phase 3 Results Show Sustained Efficacy For Up To One Year In Children With EoE (RTTNews)
18.10.23	Sanofi: PROTECT Trial Data Showcase Potential Of TZIELD - Quick Facts (RTTNews)
10.10.23	Stagwell's (STGW) The Harris Poll Unveils First-of-its-kind Global Hemophilia Survey on the Daily Challenges for Patients, Caregivers, and Providers (PR Newswire)
04.10.23	Teva To Get Up To $1.5 Bln In Deal With Sanofi To Co-develop Inflammatory Bowel Disease Treatment (RTTNews)
26.09.23	Sanofi: SBLA For Dupixent Gets Priority Review From FDA (RTTNews)
22.09.23	Sanofi: Foreign Currency To Negatively Impact Q3 Sales, Business EPS - Quick Facts (RTTNews)
14.09.23	First Wave BioPharma To Receive Global License For Capeserod From Sanofi; Stock Surges (RTTNews)
13.09.23	Sanofi and rapper/actor Ice-T unveil trailer for The Season as a warning against the flu (PR Newswire)
28.07.23	Sanofi Q2 Profit Rises, Sales Up 3.3% At CER; Raises 2023 Business EPS Guidance (RTTNews)
25.07.23	Sanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact (PR Newswire)
18.07.23	FDA Approves AstraZeneca And Sanofi's Beyfortus To Protect Infants Against RSV Disease (RTTNews)
30.06.23	SK Reports Positive Results From Phase II Study Of 21-Valent Pneumococcal Conjugate Vaccine (RTTNews)
27.06.23	Sanofi Reports Positive Topline Phase 2b Data In Atopic Dermatitis With Amlitelimab (RTTNews)
20.06.23	Sanofi Prevails In Zantac Arbitration In International Chamber Of Commerce Dispute - Quick Facts (RTTNews)
31.05.23	Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis (RTTNews)
22.05.23	Sanofi:Dupixent Phase 3 COPD Results Presented At ATS & Published In New England Journal Of Medicine (RTTNews)
19.05.23	U.S. Supreme Court Rules Against Amgen In Cholesterol Drug Patent Dispute With Sanofi (RTTNews)
18.05.23	Sanofi Applauds Supreme Court Ruling Supporting Scientific Innovation by Striking Down Amgen's Asserted PCSK9 Patent Claims in Amgen v Sanofi (PR Newswire)
12.05.23	Sanofi: Nirsevimab Delivers 83% Reduction In RSV Infant Hospitalizations In Phase 3b Trial (RTTNews)
24.04.23	Sanofi Launches Hepatitis A Vaccine In U.K For Use In Children Aged 12 Months To 15 Yrs (RTTNews)
11.04.23	Sanofi Refiles Premerger Notification And Report Form On Provention Bio Acquisition (RTTNews)
10.04.23	Sobi To Streamline Nirsevimab Agreement (RTTNews)
04.04.23	Sanofi Breaks Ground on State-of-the-Art Facility in Swiftwater for Sustainable Production of Pandemic Flu Vaccines (PR Newswire)
21.03.23	Sanofi : EU Approves Dupixent To Treat Severe Atopic Dermatitis In Children (RTTNews)
17.03.23	Sanofi To Cut U.S. List Price Of Its Most-prescribed Insulin By 78% (RTTNews)
13.03.23	Sanofi To Buy Provention Bio For Around $2.9 Bln In Cash (RTTNews)
07.03.23	Sanofi - Aventis: FDA Accepts, For Review, SBLA For Dupixent For Treatment Of CSU (RTTNews)
02.03.23	Sanofi : Phase 3 Study Of Altuviiio In Hemophilia A Meets Primary Endpoint (RTTNews)
01.03.23	FDA Approves Regeneron's Kevzara To Treat Inflammatory Rheumatic Disease (RTTNews)
24.02.23	FDA Approves Sanofi's Hemophilia Drug (RTTNews)
13.02.23	Sanofi Global Head Of R&D John Reed To Resign (RTTNews)
03.02.23	Sanofi Q4 Profit Climbs, Sees Slower Earnings Growth In FY23; Stock Down (RTTNews)
03.02.23	Sanofi Q4 Profit Climbs; Sees Higher Earnings In FY23 - Quick Facts (RTTNews)
29.01.23	Biotech Stocks Facing FDA Decision In February 2023 (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.48	2.03 %	K V
Part Grp Hldg	1’272.50	1.48 %	K V
UBS Group	27.98	1.12 %	K V
ABB	49.51	1.00 %	K V
Swiss Re	129.80	0.85 %	K V
Zurich Insur Gr	554.80	0.40 %	K V
Novartis	92.97	0.24 %	K V
Nestle	76.40	0.05 %	K V
Givaudan	3’864.00	-0.41 %	K V
CieFinRichemont	121.35	-0.45 %	K V

mehr

17.10.24		Sanofi-Aktie wenig bewegt: Sorgen der Regierung gegen Opella-Teilverkauf sollen beschwichtigt werden
04.10.24		Sanofi-Aktie gefragt: Recordati erwirbt Sanofi Enjaymo-Rechte für eine knappe Milliarde Dollar
12.09.24		Sanofi startet Kooperation zur Bekämpfung seltener Krebserkrankungen - Aktie gibt nach
11.09.24		Sanofi mit Studienerfolg: Dupixent hilft bei Hautkrankheiten - Aktie dennoch tiefer
02.09.24		Sanofi-Medikament Tolebrutinib zeigt gute Ergebnisse - Sanofi-Aktionäre begeistert
04.07.24		Sanofi-Aktie kaum bewegt: Bain und Cinven ziehen wohl Übernahme von Sanofis Consumer-Sparte in Betracht
03.07.24		Sanofi-Aktie moderat im Plus: Dupixent von Sanofi erhält EU-Zulassung für COPD-Behandlung
26.06.24		Sanofi-Aktie im Minus: Verkauf von Consumer Health steht offenbar in den Startlöchern - möglicher IPO